Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.7K
Overview
64.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Universal strategy to generate lentiviral vectors encoding lethal proteins.

Molecular therapy. Advances·2026
Same author

Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuit.

Frontiers in immunology·2026
Same author

Ecological dynamics of three persistent opportunistic pathogens in hospital sinks and their potential antagonistic bacteria.

mSystems·2026
Same author

Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors.

Cellular & molecular immunology·2025
Same author

Leveraging regulatory monitoring data for quantitative microbial risk assessment of Legionella pneumophila in cooling towers.

The Science of the total environment·2025
Same author

Mediterranean diet intervention and coronary plaque progression after acute coronary syndrome. The MEDIMACS clinical trial.

Revista espanola de cardiologia (English ed.)·2025

Related Experiment Video

Updated: May 3, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

10.5K

Allogenicity & immunogenicity in regenerative stem cell therapy.

Dominique Charron1

  • 1Laboratoire "Jean Dausset" - Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint Louis, CIB-HOG, AP-HP & INSERM UMRS 940, Institut Universitaire d'Hématologie, Université Paris-Diderot ,1, Avenue Claude Vellefaux, 75010, Paris, France.

The Indian Journal of Medical Research
|January 18, 2014
PubMed
Summary

Stem cells are crucial for regenerative medicine. Their immune properties, or allogenicity, can be both detrimental and beneficial, influencing therapeutic outcomes and requiring careful immune monitoring for safe clinical use.

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

7.2K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.1K

Related Experiment Videos

Last Updated: May 3, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

10.5K
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

7.2K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.1K

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Stem Cell Biology

Background:

  • Regenerative medicine increasingly utilizes stem cells for tissue repair and organ reconstitution.
  • While autologous stem cells were once preferred, allogeneic, or
  • off-the-shelf
  • stem cells are gaining traction due to immediate availability.
  • The allogenicity of these cells presents both challenges and opportunities for therapeutic applications.

Purpose of the Study:

  • To investigate the dual role of stem cell allogenicity in regenerative medicine.
  • To highlight the importance of immune phenotype and immuno-monitoring for clinical stem cell applications.
  • To emphasize the need for transplantation immunology knowledge in developing safe stem cell therapies.

Main Methods:

  • Review of recent scientific literature on stem cell allogenicity and regenerative effects.
  • Analysis of the detrimental (elimination) and beneficial (paracrine signaling, immune modulation) impacts of allogeneic stem cells.
  • Consideration of immuno-monitoring strategies for in vivo stem cell injections.

Main Results:

  • Allogenicity can lead to stem cell elimination but also offers regenerative benefits via paracrine effects on endogenous stem cells.
  • Stem cells possess immune modulatory capacities that can be leveraged to promote tissue regeneration.
  • The immune phenotype of stem cells is a critical factor for their clinical efficacy and safety.

Conclusions:

  • Understanding the complex role of allogenicity is essential for advancing stem cell therapies.
  • Immuno-monitoring post-transplantation is crucial for assessing the in vivo consequences of stem cell injection.
  • Integrating transplantation immunology principles will facilitate the development of safe and personalized regenerative stem cell treatments.